Trial intelligence / Profile preview

Alkali Therapy in Chronic Kidney Disease

NCT01452412Phase 3Completed

Sponsor
Albert Einstein College of Medicine
Start
Oct 2011
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sodium bicarbonate in metabolic acidosis, chronic kidney disease (CKD), sponsored by Albert Einstein College of Medicine. Started Oct 2011; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

metabolic acidosischronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT01452412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01452412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call